Hi everyone,
Enclosed already now (many thanks to all involved in the rapid approval) the rationale and the options for action when using CytoSorb in COVID-19 patients. These can be shared with interested physicians and distributors. You will find these two documents together with the current recommendations of the Italian Society of Nephrology at our website:
B1115R01ENG2020_Options_for_actions_Cytosorb_COVID19_English